What is the ROE (Return on Equity) of Biotage this year?
The ROE of Biotage this year is 0.07 undefined.
Biotage ROE 2025
Biotage ROE
0.07
Ticker
BIOT.ST
ISIN
SE0000454746
WKN
A0MNB5
In 2025, Biotage's return on equity (ROE) was 0.07, a -58.91% increase from the 0.16 ROE in the previous year.
Biotage Aktienanalyse
What does Biotage do?
Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Biotage's Return on Equity (ROE)
Biotage's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Biotage's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Biotage's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Biotage’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Biotage stock
How has the Return on Equity (ROE) of Biotage developed compared to the previous year?
The ROE of Biotage has increased by -58.91% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Biotage?
A high ROE indicates that Biotage generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Biotage?
A low ROE can indicate that Biotage is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Biotage affect the company?
A change in ROE (Return on Equity) of Biotage can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Biotage?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Biotage?
Some factors that can influence Biotage's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Biotage pay?
Over the past 12 months, Biotage paid a dividend of 1.6 SEK . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Biotage is expected to pay a dividend of 1.75 SEK.
What is the dividend yield of Biotage?
The current dividend yield of Biotage is 1.13 %.
When does Biotage pay dividends?
Biotage pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Biotage?
Biotage paid dividends every year for the past 0 years.
What is the dividend of Biotage?
For the upcoming 12 months, dividends amounting to 1.75 SEK are expected. This corresponds to a dividend yield of 1.23 %.
In which sector is Biotage located?
Biotage is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biotage kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biotage from 5/3/2024 amounting to 1.6 SEK, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.
When did Biotage pay the last dividend?
The last dividend was paid out on 5/3/2024.
What was the dividend of Biotage in the year 2024?
In the year 2024, Biotage distributed 1.6 SEK as dividends.
In which currency does Biotage pay out the dividend?
The dividends of Biotage are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biotage
Our stock analysis for Biotage Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotage Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
